![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.155 | 3.43% | 4.675 | 4.35 | 5.00 | - | 25,623 | 16:35:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.52 | 9.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/9/2020 22:34 | Here .... SNG 208p +8.00 +4.00% On the US.... SYGGF:USOTC US 2.85USD +0.20 +7.55% ------------------- DOW finished at best of the day with 215 points higher | master rsi | |
01/9/2020 21:34 | And this... in the National Geographic...To be frank, we were surprised at how effective this treatment was," says University of Southampton's Holgate, one of Synairgen's co-founders. "You could understand that if this treatment was given at the very first stage of the disease, when the virus was taking occupancy in the lungs, you would have a good effect-but here we were, able to pull people back from going on a ventilator and accelerate their recovery." | ![]() bobaxe1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions